Dr Stefan Uhrlandt joined the iSTAR Medical team as VP Research and Development (R&D) in April 2019 with over 25 years of experience in R&D, Process Management and Marketing.
Stefan’s experience includes senior global positions in industrial and medical device companies both in Germany and in the US, including Evonik (specialty chemicals), Ethicon (Johnson & Johnson Medical Devices), and most recently Alcon (previously a Novartis company). In his most recent role at Alcon, Stefan held a global role responsible for contact lenses as Senior Director R&D, Vision Care. Prior to Alcon, Stefan worked at Ethicon over a period of 8 years, lastly as Executive Group Director R&D, globally responsible for 3 product platforms and directly responsible for 5 organisational units including R&D, Innovation Management, Pre-Clinical Development, Medical Affairs and Regulatory Affairs.
Stefan has a PhD in Natural Sciences and a Masters in Chemistry from the University of Hannover (Germany), and an Executive MBA from Rutgers Business School, Newark, NJ (USA). Stefan holds several patents for inventions in the area of precipitated silica.